ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage

20260 citationsJournal Article

Authors

David Roh · Columbia University

Jonathan M. Davis · Westat (United States)

Deborah B. Bookwalter · Westat (United States)

Travis Lee · Westat (United States)

Patrick Mitchell · Westat (United States)

Elizabeth F. Stone · Columbia University

Matthew S. Karafin ·

Abstract

Acute platelet transfusion practice remains prevalent in ICH, and platelet transfusion-related 30-day mortality risk may be influenced by ABO-incompatible platelet units. Clinical trials are needed to assess whether transfusion practice changes in providing ABO-matched platelets can improve outcomes in certain patients with ICH.

Topics & Keywords

Blood transfusion and management Intracerebral and Subarachnoid Hemorrhage Research Trauma, Hemostasis, Coagulopathy, Resuscitation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Neurosurgery

DOI: 10.1227/neu.0000000000004006

Field-Weighted Citation Impact: 0.00